Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/07/2025
On Monday, the offshore Chinese yuan against the US dollar was reported at 7.1723, down 6 points from last Friday's New York closing. Trading for the day ranged between 7.1672 and 7.1758 yuan.
Latest
1 m ago
China Galaxy Securities: Positive factors in the banking sector continue to accumulate, and a turning point in performance is expected.
1 m ago
China Galaxy Securities stated that insurance funds' long-term assessment will strengthen and enhance the value of the bank sector; public funds' underweight position is expected to be repaired, with the expansion of ETFs accelerating and benefiting from the increase in funding for weight-bearing stocks, speeding up the reshaping of bank valuations. A package of financial policies will further strengthen the structural tools and boost the positive factors of the bank's fundamentals, leading to an accumulation of positive factors and an expected turning point in performance.
2 m ago
Citic Securities: Structured easing will become the main theme of the next stage of policies.
2 m ago
The CITIC Securities research report stated that government bond issuance in the social financing sector supported a slight increase in the growth rate of social financing in June. Looking ahead, with the main line of debt-to-equity conversion switching to maintain growth, and the traditional accelerated issuance of government bonds around the middle of the year, there may still be support for the performance of social financing. In terms of credit, due to factors at the mid-year point and the impact of a low base in the same period last year, banks have significantly increased lending to the supply side, such as short-term loans to the public, while the issuance of medium and long-term loans has remained relatively stable compared to the same period last year. We believe that under the background of trade friction, there is still a wait-and-see sentiment for corporate financing. Additionally, combining with real estate sales data, we judge that current mortgage demand is still relatively low, and retail recovery awaits the continued implementation of previous comprehensive policies and subsequent incremental policies. On the deposit side, the improvement in M1 is mainly driven by the low base and the repair of corporate funding, leading to an upward trend in M2, reflecting the stability of bank liabilities, which helps to sustain a loose liquidity environment. Furthermore, at the press conference on July 14, the central bank explicitly stated that "technology innovation + service consumption" is the dual focus of monetary policy. CITIC Securities believes that structural easing will become the main theme of the next stage of policy, and interest rate cuts and other total policies may remain cautious in the short term, which will help maintain a stable credit environment, but in the long term, attention still needs to be paid to the transmission effect and the pace of real economy recovery.
2 m ago
On July 15th, the global leader in the field of animal health, Boehringer Ingelheim, announced its strategic partnership intention with Jilin Zhengye Biopharmaceutical Co., Ltd. The two parties will work together to promote the commercialization of innovative cattle vaccines in the mainland Chinese market. By providing innovative prevention solutions, they aim to improve the health level of dairy and beef cattle populations, and support the transformation of animal husbandry disease prevention and control and sustainable farming.
See all latest